Michele Cecchini is a health economist/policy analyst in the OECD Health Division, where he has been working on the Economics of Prevention project since 2007. In particular, he contributed to the design of the CDP micro-simulation model and conducted analyses aimed at assessing the cost-effectiveness and distributional impacts of alternative strategies to tackle risk factors, especially physical inactivity and unhealthy diet, linked to obesity and related chronic diseases. He also contributed to the analysis of past trends and future projections of overweight and obesity. After obtaining a degree in Medicine and Surgery at the University of Genoa, Michele completed his specialist training in Public Health at the University of Siena. He also obtained a masters degree in health policy, planning and financing from the London School of Economics and the London School of Hygiene and Tropical Medicine.
Prof. Finer is Consultant Endocrinologist and Bariatric Physician at University College Hospitals, London, honorary Professor in the National Centre for Cardiovascular Prevention and Outcomes, UCL Institute of Cardiovascular Science. He is past chairman of the UK Association for the Study of Obesity, chair of the IASO Education and Management Task Force and editor of Clinical Obesity. He is a Fellow of the UK Royal College of Physicians, Association for Nutrition and North American Obesity Association. He sits on various Government and NHS obesity committees and published widely on research into obesity treatment.
Teodora Hanfjieva-Darlenska graduated medicine in Medical Faculty, Medical University in Sofia in 2005. Then, she defended her two PhD levels in Bulgaria (2009) and in Denmark (2011) in the field of pharmacology and nutrition and obesity. In 2010, she took her pharmacology specialty and from 2011 till now she is specializing in nutrition and dietetics. Dr Handjieva-Darlenska is a Chief Assistant in Department of pharmacology and toxicology in Medical Faculty, Medical University in Sofia. She is member of the Young Investigators United (YIU) of the European Association for the Study of Obesity (EASO) as well as member of the International scientific committees, resp. of the 20th International congress on nutrition (Granada, September 15-20, 2013) and of the 21st European congress on obesity (Sofia, May 28-31, 2014). Dr Handjieva-Darlenska is a chief investigator in two pan-European dietary interventions: the DiOGenes trial (2005-2009), funded by the 6th Framework Program of the European Union, and the PREVIEW trial (2013-2017), funded by the 7th Framework Program of the European Union. Her main research interests are in the field of nutrition and obesity, and pharmacology.
Philip James, President of IASO completes his 6 years in office with this Congress. He trained in physiology, biochemistry and medicine at University College London, UK and had post-graduate training in the UK, in Jamaica with the UK MRC and in the US with the Wellcome Trust. He was secretary of the first UK MRC and Dept. of Health report on obesity research in 1976, wrote the obesity report for the Royal College of Physicians in 1983, established the MRC Dunn Clinical Nutrition Centre in Cambridge building both indirect and direct calorimeters to study energy balance in obesity, chaired the UK’s first public health approach to obesity and later on childhood obesity, chaired the first SIGN guidelines on obesity management and established and ran the International Obesity Task Force for a decade. He organised the first WHO global analysis of obesity, developed the organisation of the current IASO and undertook the first global burden analyses for WHO on obesity 12 years ago. He was Director of the Rowett Research Institute in Aberdeen for 17 years and is now chief advisor on nutritional aspects of public health initiatives for WHO EURO and EMRO covering 75 countries.
Stephen Jan is the Head of the Health Economics Program at the George Institute for Global Health and Professor of Health Economics at the Sydney Medical School, University of Sydney. He leads a program of research into the economics of chronic disease, with a particular focus on economic evaluation and the household economic impact of chronic diseases; with much of this work being carried out in Asia e.g. the ACTION study which is currently underway prospective cohort study to assess the household economic burden of cancer in over 9000 patients across 8 countries in Asia. Over his career has advised many local and international agencies including Australian national and state governments, the US Institute of Medicine and the World Health Organisation. He has a strong interest in chronic disease prevention and the establishment of appropriate measures outcome in that field.
Dr Kamaliah Binti Mohamad Noh heads the Primary Health Care Section of the Family Health Development Division, which is responsible for development of primary healthcare operational policies in implementing national health policies to attain public health goals of the country. At the global health level, its work directly contributes to the nation’s efforts in attaining global public health targets, for example, the United Nation’s Millenium Development Goals health related targets specifically MDG 4, 5 and 6; “Every woman every child”; UNICEF’s “Child Survival: Call to Action”; WHO’s “health system strengthening” using the primary healthcare approach and values; “Health in All Policies” applying the social determinants of health in the development and planning of health services. Areas of interest include social determinants of health and rural health, especially delivery of health to the hard-to-reach populations and primary health care reform towards the Malaysian health system reform.
Associate Professor Marj Moodie is a Principal Research Fellow at Deakin University where she is Deputy Head (Research) of the Deakin Health Economics. In her role as a health economist, her work is focussed on economic evaluation and priority setting, primarily in the field of obesity, NCDs and stroke. She has conducted the economic evaluation of a range of preventive interventions for obesity, including several large community-based obesity prevention projects based in Victoria, Australia and the Pacific. She has been a leading player in the successful ACE (Assessing Cost-Effectiveness) priority setting studies around obesity, both in Australia and the United States of America. Associate Professor Moodie coordinates a team of researchers and PhD students working on the economics of obesity, and coordinates Deakin University’s new Centre for Research Excellence in Obesity Policy and Food Systems.
Jennifer L. Pomeranz, JD, MPH, is an Assistant Professor in Public Health at Temple University. Prior to joining the Temple faculty, Ms. Pomeranz was the Director of Legal Initiatives at the Yale Rudd Center for Food Policy and Obesity at Yale University and an Adjunct Instructor at New York University Steinhardt School. Ms. Pomeranz speaks and publishes on subjects including: the First Amendment, pre-emption, regulating over-the-counter products, food labeling, weight discrimination, food marketing to children, and innovative legal solutions to obesity. Ms. Pomeranz is the Policy Chair of the Health Law Section of the American Public Health Association and the official liaison between the American Academy of Paediatrics and the American Public Health Association. She earned her Juris Doctorate from Cornell Law School, and her Masters of Public Health from the Harvard School of Public Health.
Sinne Smed is an assistant professor at the Department of Food and Resource Economics at the University of Copenhagen. She uses econometric methods to evaluate and simulate the effects of different policy instruments to regulate consumer behavior in relation to health behavior.